Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NYSE:PBYI)

29.09
Delayed Data
As of Jun 28
 +1.29 / +4.64%
Today’s Change
19.74
Today|||52-Week Range
119.36
-62.90%
Year-to-Date
'Mad Money' Lightning Round: I Like Sirius XM Radio
6:07am / TheStreet.com - Paid Partner Content
Puma (PBYI) Submits Neratinib Marketing Application in EU
Jun 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close27.80
Today’s open28.50
Day’s range28.08 - 29.40
Volume695,877
Average volume (3 months)748,200
Market cap$945.2M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)-57.51%
Earnings growth (this year)-12.84%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+1.01+5.60%
CLLSCellectis SA+0.63+2.49%
SAGESAGE Therapeutics In...+1.29+4.78%
DERMDermira Inc+1.37+5.01%
Data as of 06/28/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$2.18
Annual revenue (last year)$0.00
Annual profit (last year)-$239.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs